Drug · DIN 02082136
GENTAMICIN(E)
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 31, 1995; first marketed December 31, 1995.
- Drug Identification Number (DIN)
- 02082136
- Company (DIN owner)
- Baxter CorporationMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Gentamicin J01GB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GENTAMICIN (GENTAMICIN SULFATE) | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 16, 1994: NOC 5974Supplement to a New Drug Submission (SNDS) · New strength
- March 16, 1994: NOC 5977Supplement to a New Drug Submission (SNDS) · Change in product name
Other DINs named GENTAMICIN(E)
- DIN 02082152 · Marketed